Q4 Results: Weak Outlook Spooks Lupin’s Shareholders
Ramipril capsules move along the production line at the Lupin Ltd. pharmaceutical plant in Salcette, Goa. ( Photographer: Dhiraj Singh/Bloomberg)

Q4 Results: Weak Outlook Spooks Lupin’s Shareholders

Shares of Lupin Ltd. fell close to 10 percent as the company guided for higher tax rates in the next few years due to higher proportion of profits from India.The drugmaker guided for a tax rate of ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.